Owens & Minor (OMI) to Release Quarterly Earnings on Friday

Owens & Minor (NYSE:OMI - Get Free Report) is projected to post its Q2 2025 quarterly earnings results before the market opens on Friday, August 1st. Analysts expect Owens & Minor to post earnings of $0.27 per share and revenue of $2.73 billion for the quarter.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its earnings results on Saturday, May 10th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.03. Owens & Minor had a positive return on equity of 17.09% and a negative net margin of 3.41%. During the same period last year, the firm earned $0.19 EPS. The business's quarterly revenue was up .7% on a year-over-year basis. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Owens & Minor Price Performance

Shares of NYSE:OMI remained flat at $7.88 during midday trading on Monday. The company had a trading volume of 706,445 shares, compared to its average volume of 925,448. The company has a quick ratio of 0.41, a current ratio of 1.13 and a debt-to-equity ratio of 3.32. Owens & Minor has a 12 month low of $6.07 and a 12 month high of $16.85. The company has a market capitalization of $608.77 million, a price-to-earnings ratio of -1.66, a price-to-earnings-growth ratio of 0.35 and a beta of 1.40. The business's 50 day moving average price is $7.78 and its two-hundred day moving average price is $8.63.

Analyst Ratings Changes

OMI has been the topic of a number of analyst reports. Citigroup decreased their price objective on Owens & Minor from $13.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, April 17th. Robert W. Baird boosted their price objective on Owens & Minor from $9.00 to $10.00 and gave the company a "neutral" rating in a research note on Friday, June 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Owens & Minor presently has a consensus rating of "Hold" and a consensus price target of $11.60.

Hedge Funds Weigh In On Owens & Minor

A number of institutional investors have recently added to or reduced their stakes in OMI. Royal Bank of Canada increased its stake in Owens & Minor by 60.1% in the 1st quarter. Royal Bank of Canada now owns 83,565 shares of the company's stock worth $754,000 after acquiring an additional 31,368 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Owens & Minor by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 44,787 shares of the company's stock worth $404,000 after acquiring an additional 1,857 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Owens & Minor by 43.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 576,799 shares of the company's stock worth $5,208,000 after acquiring an additional 175,866 shares during the last quarter. Woodline Partners LP bought a new position in Owens & Minor in the 1st quarter worth about $613,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Owens & Minor by 11.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 243,826 shares of the company's stock worth $2,202,000 after acquiring an additional 24,065 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.